Nai-Chen Cheng and his team in Taipei weren’t working with live axolotls the day they made a breakthrough—they were holding a translucent, gel-like scaffold derived from the skin of the amphibian famed for regrowing entire limbs. Yet this cell-free material, stripped of living cells but rich in regenerative signals, might one day help humans heal like salamanders. In a study published in Materials Today Bio, Cheng’s team at National Taiwan University revealed that their axolotl-derived extracellular matrix (ECM) dramatically accelerated wound closure and reduced scarring in mice with burn injuries—offering a glimpse of a future where wounds regenerate rather than scar.
Scarring is more than cosmetic. For burn survivors, surgical patients, and those with chronic wounds, fibrotic tissue can impair movement, sensation, and quality of life. The body’s default healing response—flooded with inflammation and dense, disorganized collagen—closes the wound but fails to restore true skin architecture. Axolotls, by contrast, heal seamlessly. Inspired by this, Cheng and his colleagues processed axolotl skin to remove cells while preserving the ECM, the intricate network of proteins and biochemical cues that guide tissue repair. After purifying the material to enhance its biocompatibility, they applied it to burn wounds in mice.
The results were striking. Wounds treated with the axolotl ECM closed significantly faster than those treated with saline or even mouse-derived ECM. By day 14, the treated wounds showed a more organized epidermal layer and collagen fibers aligned in a basket-weave pattern—resembling healthy skin—rather than the dense, parallel bundles typical of scars. Molecular analysis revealed a shift in the wound environment: pro-inflammatory signals like TNF-α and IL-6 were reduced, while markers linked to regenerative immune responses increased. Crucially, activity of TGF-β1, a key driver of fibrosis, was suppressed, suggesting the material actively steered healing away from scarring.
Even more remarkable, the scaffold supported the growth of human skin cells in lab cultures, hinting at cross-species potential. While the research is still in preclinical stages—tested only in cells and mice—the implications are profound. If these effects translate to humans, such biomaterials could transform wound care, particularly for burn victims and those prone to keloids or chronic non-healing wounds.
This isn’t about transplanting salamander parts—it’s about learning their language of regeneration. As Cheng puts it, the goal is to "guide human wounds toward more complete repair." The team now aims to scale production, test long-term safety, and explore delivery methods, from injectable gels to advanced dressings. In a world where over 100 million people acquire scars each year, this tiny matrix from a Mexican amphibian may carry outsized hope.